Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Leitman

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
The New England Journal of Medicine|October 5, 1989
Clinical implications of positive tests for antibodies to human immunodeficiency virus type 1 in asymptomatic blood donorsS F Leitman, H G Klein, J J Melpolder, et al.
British Journal of Haematology|November 28, 2001
Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-backR Nakamura, E Bahceci, E J Read, et al.
British Journal of Haematology|February 24, 2005
Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantationL M Griffith, J P McCoy, C D Bolan, et al.
Blood|June 1, 1997
Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivoR V Emmons, S Doren, J Zujewski, et al.
The American Journal of Cardiology|October 25, 1992
Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The Liposorber Study GroupB R Gordon, S F Kelsey, D W Bilheimer, et al.
Cancer|March 15, 1994
Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with responseB A Pockaj, R M Sherry, J P Wei, et al.
Blood|July 11, 2000
Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adultsC L Mackall, D Stein, T A Fleisher, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanomaM E Dudley, J Wunderlich, M I Nishimura, et al.
AIDS (London, England)|December 28, 2000
Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort StudyD H McDermott, M J Beecroft, C A Kleeberger, et al.
The New England Journal of Medicine|March 22, 2001
Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograftM E Horwitz, A J Barrett, M R Brown, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|October 5, 1989
Clinical implications of positive tests for antibodies to human immunodeficiency virus type 1 in asymptomatic blood donorsS F Leitman, H G Klein, J J Melpolder, et al.
British Journal of Haematology|November 28, 2001
Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-backR Nakamura, E Bahceci, E J Read, et al.
British Journal of Haematology|February 24, 2005
Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantationL M Griffith, J P McCoy, C D Bolan, et al.
Blood|June 1, 1997
Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivoR V Emmons, S Doren, J Zujewski, et al.
The American Journal of Cardiology|October 25, 1992
Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The Liposorber Study GroupB R Gordon, S F Kelsey, D W Bilheimer, et al.
Cancer|March 15, 1994
Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with responseB A Pockaj, R M Sherry, J P Wei, et al.
Blood|July 11, 2000
Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adultsC L Mackall, D Stein, T A Fleisher, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanomaM E Dudley, J Wunderlich, M I Nishimura, et al.
AIDS (London, England)|December 28, 2000
Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort StudyD H McDermott, M J Beecroft, C A Kleeberger, et al.
The New England Journal of Medicine|March 22, 2001
Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograftM E Horwitz, A J Barrett, M R Brown, et al.
Pageof 8